NASDAQ:ALGN - Align Technology Stock Price, Price Target & More

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) issued its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.19. The medical equipment provider had revenue of $436.92 million for the quarter, compared to analyst estimates of $408.27 million. Align Technology had a net margin of 16.12% and a return on equity of 30.36%. The firm's revenue for the quarter was up 40.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.59 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Align Technology.

Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.

15 brokers have issued 12 month target prices for Align Technology's stock. Their forecasts range from $193.00 to $410.00. On average, they anticipate Align Technology's stock price to reach $298.20 in the next year. View Analyst Ratings for Align Technology.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), Invacare (IVC), CONSORT Med PLC/S (CSRMY), Sientra (SIEN) and RTI Surgical (RTIX).

Media coverage about ALGN stock has trended somewhat negative on Saturday, Accern Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Align Technology earned a coverage optimism score of -0.05 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 48.56 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Align Technology's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.32%), Polen Capital Management LLC (3.33%), Disciplined Growth Investors Inc. MN (1.20%), Old Mutual Global Investors UK Ltd. (0.90%), Federated Investors Inc. PA (0.72%) and Victory Capital Management Inc. (0.61%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Fiera Capital Corp, Victory Capital Management Inc., Ownership Capital B.V., Smith Asset Management Group LP, Frontier Capital Management Co. LLC, BlackRock Inc. and Sei Investments Co.. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

ALGN stock was bought by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, TCW Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, Prudential Financial Inc., Carillon Tower Advisers Inc., Polen Capital Management LLC and Motley Fool Asset Management LLC. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $353.27.

Align Technology has a market capitalization of $28.82 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]